ROCKETS - a novel one-for-all toolbox for light sheet microscopy in drug discovery.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 01 09 2022
accepted: 06 01 2023
entrez: 27 2 2023
pubmed: 28 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Advancing novel immunotherapy strategies requires refined tools in preclinical research to thoroughly assess drug targets, biodistribution, safety, and efficacy. Light sheet fluorescence microscopy (LSFM) offers unprecedented fast volumetric

Identifiants

pubmed: 36845124
doi: 10.3389/fimmu.2023.1034032
pmc: PMC9945347
doi:

Substances chimiques

Epithelial Cell Adhesion Molecule 0
Receptor Protein-Tyrosine Kinases EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1034032

Informations de copyright

Copyright © 2023 Mueller, Dobosz, O’Brien, Abdoush, Giusti, Lechmann, Osl, Wolf, Arellano-Viera, Shaikh, Sauer, Rosenwald, Herting, Umaña, Colombetti, Pöschinger and Beilhack.

Déclaration de conflit d'intérêts

JM, NO, TP, AG, SC, FH, NA, PU, MD, FO, A-KW are current or former employees of F. Hoffmann-La Roche AG, Switzerland, or one of its subsidiaries, and declare co-authorship of patents, awarded to Roche Holding AG and/or declare stock ownership in the Roche Holding AG. AB is a scientific cofounder of Aamuthera Biotech GmbH and Dualyx NV. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.

Références

Eur J Immunol. 1996 Feb;26(2):401-8
pubmed: 8617310
Nat Med. 2017 May 5;23(5):540-547
pubmed: 28475571
Cell Res. 2020 Jun;30(6):507-519
pubmed: 32467593
Nat Rev Cancer. 2015 Jun;15(6):347-60
pubmed: 25998714
Cancer Res. 1987 Jun 1;47(11):2883-91
pubmed: 3552208
Nat Med. 2011 Dec 25;18(1):166-71
pubmed: 22198277
Nat Neurosci. 2015 Oct;18(10):1518-29
pubmed: 26368944
Nat Commun. 2020 Apr 8;11(1):1746
pubmed: 32269212
Cancers (Basel). 2018 Jan 12;10(1):
pubmed: 29329202
Antibodies (Basel). 2020 Jul 20;9(3):
pubmed: 32698317
Cell. 2016 Jun 16;165(7):1789-1802
pubmed: 27238021
Int J Biochem Cell Biol. 2017 Mar;84:35-39
pubmed: 28082099
Nat Protoc. 2012 Nov;7(11):1983-95
pubmed: 23060243
Mol Ther Methods Clin Dev. 2018 Jan 31;8:183-197
pubmed: 29541646
Nat Med. 2012 Jun;18(6):980-7
pubmed: 22561687
Front Neurosci. 2015 Mar 03;9:32
pubmed: 25784848
Front Immunol. 2019 Aug 28;10:2040
pubmed: 31555271
Nat Protoc. 2015 Nov;10(11):1860-1896
pubmed: 26492141
Cell Chem Biol. 2016 Jan 21;23(1):137-157
pubmed: 26933741
Development. 2019 Feb 1;146(3):
pubmed: 30665888
Histochemistry. 1987;87(5):491-8
pubmed: 3323146
Carcinogenesis. 2010 Nov;31(11):1913-21
pubmed: 20837599
Nat Neurosci. 2011 Aug 30;14(11):1481-8
pubmed: 21878933
Br J Cancer. 2015 Dec 1;113(11):1548-55
pubmed: 26554649
N Engl J Med. 2018 Jul 5;379(1):64-73
pubmed: 29972754
Cell Rep. 2018 Aug 21;24(8):2196-2210.e9
pubmed: 30134179
Nature. 1967 Jul 15;215(5098):315
pubmed: 6059528
Arch Oral Biol. 2017 Jul;79:87-94
pubmed: 28347886
Int Rev Cytol. 1991;127:57-109
pubmed: 1880006
Nat Rev Immunol. 2020 Feb;20(2):75-76
pubmed: 31925406
J Clin Invest. 2012 Dec;122(12):4439-46
pubmed: 23143304
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
Cerebrospinal Fluid Res. 2007 Dec 27;4:11
pubmed: 18162136
mBio. 2020 Feb 4;11(1):
pubmed: 32019790
Am J Physiol Gastrointest Liver Physiol. 2020 Jul 1;319(1):G1-G10
pubmed: 32421359
Nat Rev Drug Discov. 2017 May;16(5):315-337
pubmed: 28303026
Nat Methods. 2007 Apr;4(4):331-6
pubmed: 17384643
Cell. 2015 Jul 16;162(2):246-257
pubmed: 26186186
Nat Rev Drug Discov. 2010 Apr;9(4):325-38
pubmed: 20305665
Neoplasia. 2014 Jan;16(1):1-13
pubmed: 24563615
Development. 2016 Nov 1;143(21):3969-3981
pubmed: 27803058
iScience. 2020 Aug 21;23(8):101432
pubmed: 32805648
Lancet Oncol. 2017 Dec;18(12):e731-e741
pubmed: 29208439
Front Pharmacol. 2018 Aug 14;9:802
pubmed: 30154715
Adv Drug Deliv Rev. 2004 Mar 27;56(5):603-18
pubmed: 15019749
Am J Surg Pathol. 2000 Jul;24(7):1016-9
pubmed: 10895825
Oncoimmunology. 2018 Apr 18;7(8):e1450710
pubmed: 30221040
J Vis Exp. 2012 Jul 30;(65):
pubmed: 22871843
Annu Rev Cell Dev Biol. 2016 Oct 6;32:713-741
pubmed: 27298088
Proc Natl Acad Sci U S A. 1979 Mar;76(3):1438-42
pubmed: 286328
Adv Drug Deliv Rev. 2004 Oct 14;56(12):1695-716
pubmed: 15381330
Transgenic Res. 2008 Apr;17(2):229-38
pubmed: 17940847
Nat Rev Clin Oncol. 2020 Jul;17(7):418-434
pubmed: 32242094
Exp Mol Pathol. 2019 Dec;111:104302
pubmed: 31465765
Histochem Cell Biol. 2016 Dec;146(6):781-806
pubmed: 27704211
Biochem Biophys Res Commun. 2016 Oct 14;479(2):305-311
pubmed: 27639649
Nat Protoc. 2021 Jun;16(6):2732-2748
pubmed: 34021294
Ann Oncol. 2007 Oct;18(10):1704-7
pubmed: 17693421
Science. 2002 Sep 27;297(5590):2256-9
pubmed: 12215650
Cancer Metastasis Rev. 2020 Sep;39(3):969-987
pubmed: 32507912
J Biomed Opt. 2016 Aug;21(8):081205
pubmed: 27020691
Dev Biol. 2012 Nov 15;371(2):136-45
pubmed: 22819673
Clin Cancer Res. 2004 Nov 15;10(22):7555-65
pubmed: 15569986
Cell. 2014 Apr 24;157(3):726-39
pubmed: 24746791
Nat Neurosci. 2019 Feb;22(2):317-327
pubmed: 30598527
Nat Rev Drug Discov. 2022 Apr;21(4):261-282
pubmed: 35105974
Nat Protoc. 2021 Jan;16(1):239-262
pubmed: 33247285
Hum Pathol. 2004 Jan;35(1):122-8
pubmed: 14745734
Development. 2016 Feb 15;143(4):554-65
pubmed: 26884394
Anat Embryol (Berl). 1999 Apr;199(4):291-9
pubmed: 10195304
Nephron Exp Nephrol. 2007;107(4):e119-31
pubmed: 18025791
Nat Rev Neurosci. 2020 Feb;21(2):61-79
pubmed: 31896771
Nature. 2019 Jan;565(7738):240-245
pubmed: 30568303
Cell. 2017 Mar 23;169(1):161-173.e12
pubmed: 28340341
Cancer Discov. 2021 Apr;11(4):838-857
pubmed: 33811120
Nat Rev Clin Oncol. 2019 Jun;16(6):372-385
pubmed: 30837712
Nat Rev Cancer. 2015 Jun;15(6):361-70
pubmed: 25998715
Gastroenterology. 2009 Aug;137(2):453-65
pubmed: 19447107
Curr Protoc Mouse Biol. 2016 Jun 01;6(2):148-168
pubmed: 27248432
Cell Res. 2018 Aug;28(8):803-818
pubmed: 29844583
Appl Spectrosc. 2018 Aug;72(8):1137-1169
pubmed: 29926744
Nat Rev Cancer. 2021 Nov;21(11):718-730
pubmed: 34331034
Mucosal Immunol. 2016 Mar;9(2):468-78
pubmed: 26329428
Nature. 2001 Mar 1;410(6824):101-5
pubmed: 11242050
Nat Methods. 2010 Aug;7(8):637-42
pubmed: 20601950
Nat Rev Cancer. 2014 Feb;14(2):135-46
pubmed: 24457417
Biochim Biophys Acta. 2013 Aug;1828(8):1989-2001
pubmed: 23618806
J Immunol. 1992 Jan 15;148(2):590-6
pubmed: 1729376
Haematologica. 2021 Aug 01;106(8):2147-2160
pubmed: 32675225
Nat Protoc. 2016 Sep;11(9):1617-29
pubmed: 27560169
Sci Immunol. 2018 Jan 12;3(19):
pubmed: 29330161
Theranostics. 2022 Jan 1;12(4):1486-1499
pubmed: 35198053
Blood. 2018 Apr 19;131(16):1858-1869
pubmed: 29463561
Sci Rep. 2017 Aug 24;7(1):9269
pubmed: 28839164
Nat Rev Clin Oncol. 2021 Jun;18(6):327-344
pubmed: 33558752
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
Trends Pharmacol Sci. 2016 Dec;37(12):1009-1028
pubmed: 27745709
Sci Rep. 2021 Jul 7;11(1):14062
pubmed: 34234256
Nat Rev Immunol. 2014 Oct;14(10):667-85
pubmed: 25234148
Lab Anim. 1981 Jan;15(1):57-9
pubmed: 7022018
Nat Med. 2012 May;18(5):807-815
pubmed: 22466705
Crit Rev Oncol Hematol. 2019 Mar;135:21-29
pubmed: 30819443
Int J Mol Med. 2018 Oct;42(4):1771-1785
pubmed: 30015855
Lab Invest. 2006 May;86(5):526-33
pubmed: 16534499
Cell. 2014 Nov 6;159(4):896-910
pubmed: 25417164
Front Immunol. 2021 Jul 26;12:689896
pubmed: 34381447
J Vis Exp. 2016 Jul 13;(113):
pubmed: 27501188
Biomed Opt Express. 2019 Sep 19;10(10):5251-5267
pubmed: 31646045
Sci Rep. 2020 Oct 19;10(1):17619
pubmed: 33077794
J Mol Med (Berl). 1999 Oct;77(10):699-712
pubmed: 10606205
Eur J Immunol. 1996 Jan;26(1):110-4
pubmed: 8566052
Blood Adv. 2022 Apr 12;6(7):2195-2206
pubmed: 34861679

Auteurs

Joerg P J Mueller (JPJ)

Interdisciplinary Center for Clinical Research Laboratory (IZKF) Würzburg, Department of Internal Medicine II, Center for Experimental Molecular Medicine, Würzburg University Hospital, Würzburg, Germany.
Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Michael Dobosz (M)

Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Nils O'Brien (N)

Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Nassri Abdoush (N)

Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Anna Maria Giusti (AM)

Roche Pharmaceutical Research and Early Development, Roche Glycart AG, Schlieren, Switzerland.

Martin Lechmann (M)

Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Franz Osl (F)

Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Ann-Katrin Wolf (AK)

Interdisciplinary Center for Clinical Research Laboratory (IZKF) Würzburg, Department of Internal Medicine II, Center for Experimental Molecular Medicine, Würzburg University Hospital, Würzburg, Germany.
Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Estibaliz Arellano-Viera (E)

Interdisciplinary Center for Clinical Research Laboratory (IZKF) Würzburg, Department of Internal Medicine II, Center for Experimental Molecular Medicine, Würzburg University Hospital, Würzburg, Germany.

Haroon Shaikh (H)

Interdisciplinary Center for Clinical Research Laboratory (IZKF) Würzburg, Department of Internal Medicine II, Center for Experimental Molecular Medicine, Würzburg University Hospital, Würzburg, Germany.

Markus Sauer (M)

Department of Biotechnology and Biophysics, Biocenter, University of Würzburg, Würzburg, Germany.

Andreas Rosenwald (A)

Institute of Pathology, University of Würzburg, Würzburg, Germany.

Frank Herting (F)

Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Pablo Umaña (P)

Roche Pharmaceutical Research and Early Development, Roche Glycart AG, Schlieren, Switzerland.

Sara Colombetti (S)

Roche Pharmaceutical Research and Early Development, Roche Glycart AG, Schlieren, Switzerland.

Thomas Pöschinger (T)

Pharmaceutical Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany.

Andreas Beilhack (A)

Interdisciplinary Center for Clinical Research Laboratory (IZKF) Würzburg, Department of Internal Medicine II, Center for Experimental Molecular Medicine, Würzburg University Hospital, Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH